MII IG Kerndatensatz-Modul Seltene Erkrankungen
2027.0.0-ballot -
Germany
This page is part of the MII Implementation Guide Seltene Erkrankungen (v2027.0.0-ballot: 2027 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
| Active Stand: 2026-09-14 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="mii-vs-seltene-nbs-acylcarnitine-dbs"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareablevalueset"/>
<profile
value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishablevalueset"/>
</meta>
<language value="de"/>
<text>
<status value="generated"/>
<div xml:lang="de" lang="de"><hr/><p><b>German</b></p><hr/><p class="res-header-id"><b>Generated Narrative: ValueSet mii-vs-seltene-nbs-acylcarnitine-dbs</b></p><a name="de-mii-vs-seltene-nbs-acylcarnitine-dbs"> </a><a name="de-hcmii-vs-seltene-nbs-acylcarnitine-dbs"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profiles: <a href="http://hl7.org/fhir/uv/crmi/STU2/StructureDefinition-crmi-shareablevalueset.html">CRMI Shareable ValueSet</a>, <a href="http://hl7.org/fhir/uv/crmi/STU2/StructureDefinition-crmi-publishablevalueset.html">CRMI Publishable ValueSet</a></p></div><ul><li>Include these codes as defined in <a href="http://loinc.org"><code>http://loinc.org</code></a><span title="Version is not explicitly stated. No matching Code System found"> version Not Stated (use latest from terminology server)</span><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href="https://loinc.org/50102-3/">50102-3</a></td><td>3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53189-7/">53189-7</a></td><td>3-Hydroxydodecanoylcarnitine (C12-OH) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53173-1/">53173-1</a></td><td>3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/50106-4/">50106-4</a></td><td>3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53171-5/">53171-5</a></td><td>3-Hydroxyisovalerylcarnitine (C5-OH)/Carnitine.free (C0) [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/53172-3/">53172-3</a></td><td>3-Hydroxyisovalerylcarnitine (C5-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/50109-8/">50109-8</a></td><td>3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/50113-0/">50113-0</a></td><td>3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/50121-3/">50121-3</a></td><td>3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/50125-4/">50125-4</a></td><td>3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53201-0/">53201-0</a></td><td>3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/50132-0/">50132-0</a></td><td>3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53196-2/">53196-2</a></td><td>3-Hydroxytetradecadienoylcarnitine (C14:2-OH) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/50281-5/">50281-5</a></td><td>3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53197-0/">53197-0</a></td><td>3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/50157-7/">50157-7</a></td><td>Acetylcarnitine (C2) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53237-4/">53237-4</a></td><td>Acrylylcarnitine (C3:1) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/38474-3/">38474-3</a></td><td>Acylcarnitine [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/43717-8/">43717-8</a></td><td>Acylcarnitine [Presence] in DBS</td></tr><tr><td><a href="https://loinc.org/74628-9/">74628-9</a></td><td>Adipoylcarnitine (C6-DC) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53613-6/">53613-6</a></td><td>Benzoylcarnitine (BzCn) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53065-9/">53065-9</a></td><td>Butyrylcarnitine (C4) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53180-6/">53180-6</a></td><td>Decadienoylcarnitine (C10:2) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/45197-1/">45197-1</a></td><td>Decanoylcarnitine (C10) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/45198-9/">45198-9</a></td><td>Decenoylcarnitine (C10:1) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53214-3/">53214-3</a></td><td>Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53213-5/">53213-5</a></td><td>Dicarboxydodecenoylcarnitine (C12:1-DC) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53218-4/">53218-4</a></td><td>Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53220-0/">53220-0</a></td><td>Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53219-2/">53219-2</a></td><td>Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53216-8/">53216-8</a></td><td>Dicarboxytetradecanoylcarnitine (C14-DC) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53215-0/">53215-0</a></td><td>Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/45199-7/">45199-7</a></td><td>Dodecanoylcarnitine (C12) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/45200-3/">45200-3</a></td><td>Dodecenoylcarnitine (C12:1) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53462-8/">53462-8</a></td><td>Eicosanoylcarnitine (C20) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/45207-8/">45207-8</a></td><td>Glutarylcarnitine (C5-DC) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/88016-1/">88016-1</a></td><td>Glutarylcarnitine (C5-DC)/Acetylcarnitine (C2) [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/75225-3/">75225-3</a></td><td>Glutarylcarnitine (C5-DC)/Carnitine (C0) [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/75216-2/">75216-2</a></td><td>Glutarylcarnitine (C5-DC)/Malonylcarnitine (C3-DC) [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/75267-5/">75267-5</a></td><td>Glutarylcarnitine (C5-DC)/Palmitoylcarnitine (C16) [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/88017-9/">88017-9</a></td><td>Glutarylcarnitine (C5-DC)/Propionylcarnitine (C3) [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/53204-4/">53204-4</a></td><td>Heptanoylcarnitine (C7) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/45211-0/">45211-0</a></td><td>Hexanoylcarnitine (C6) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/45213-6/">45213-6</a></td><td>Isobutyrylcarnitine (C4) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/42920-9/">42920-9</a></td><td>Isovalerylcarnitine (C5) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/45217-7/">45217-7</a></td><td>Linoleoylcarnitine (C18:2) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/54462-7/">54462-7</a></td><td>Malonylcarnitine (C3-DC) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/75212-1/">75212-1</a></td><td>Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/45222-7/">45222-7</a></td><td>Methylmalonylcarnitine (C4-DC) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53181-4/">53181-4</a></td><td>Methylmalonylcarnitine (C4-DC)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/53207-7/">53207-7</a></td><td>Nonanoylcarnitine (C9) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53175-6/">53175-6</a></td><td>Octanoylcarnitine (C8) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53176-4/">53176-4</a></td><td>Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/53177-2/">53177-2</a></td><td>Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/88014-6/">88014-6</a></td><td>Octanoylcarnitine (C8)/Carnitine.free (C0) [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/53174-9/">53174-9</a></td><td>Octenoylcarnitine (C8:1) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53202-8/">53202-8</a></td><td>Oleoylcarnitine (C18:1) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53199-6/">53199-6</a></td><td>Palmitoylcarnitine (C16) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/88015-3/">88015-3</a></td><td>Palmitoylcarnitine (C16)/Acetylcarnitine (C2) [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/88024-5/">88024-5</a></td><td>Palmitoylcarnitine (C16)/Carnitine.free (C0) [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/54475-9/">54475-9</a></td><td>Pimeloylcarnitine (C7-DC) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53160-8/">53160-8</a></td><td>Propionylcarnitine (C3) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53163-2/">53163-2</a></td><td>Propionylcarnitine (C3)/Acetylcarnitine (C2) [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/53162-4/">53162-4</a></td><td>Propionylcarnitine (C3)/Carnitine.free (C0) [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/53164-0/">53164-0</a></td><td>Propionylcarnitine (C3)/Palmitoylcarnitine (C16) [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/53161-6/">53161-6</a></td><td>Propionylcarnitine (C3)/Methionine [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/53241-6/">53241-6</a></td><td>Stearoylcarnitine (C18) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53400-8/">53400-8</a></td><td>Stearoylcarnitine (C18)/Propionylcarnitine (C3) [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/53210-1/">53210-1</a></td><td>Suberylcarnitine (C8-DC) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53190-5/">53190-5</a></td><td>Tetradecadienoylcarnitine (C14:2) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53192-1/">53192-1</a></td><td>Tetradecanoylcarnitine (C14) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53191-3/">53191-3</a></td><td>Tetradecenoylcarnitine (C14:1) [Moles/volume] in DBS</td></tr><tr><td><a href="https://loinc.org/53193-9/">53193-9</a></td><td>Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/53194-7/">53194-7</a></td><td>Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/88025-2/">88025-2</a></td><td>Tetradecenoylcarnitine (C14:1)/Carnitine.free (C0) [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/53195-4/">53195-4</a></td><td>Tetradecenoylcarnitine (C14:1)/Palmitoylcarnitine (C16) [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/70159-9/">70159-9</a></td><td>Tetradecenoylcarnitine (C14:1)/Tetradecanoylcarnitine (C14) [Molar ratio] in DBS</td></tr><tr><td><a href="https://loinc.org/53170-7/">53170-7</a></td><td>Tiglylcarnitine (C5:1) [Moles/volume] in DBS</td></tr></table></li></ul></div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability">
<valueCode value="shareable"/>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability">
<valueCode value="publishable"/>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability">
<valueCode value="computable"/>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/artifact-versionPolicy">
<valueCodeableConcept>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/artifact-version-policy-codes"/>
<code value="package"/>
<display value="Package"/>
</coding>
</valueCodeableConcept>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/resource-approvalDate">
<valueDate value="2026-09-02"/>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-topic">
<valueCodeableConcept>
<coding>
<system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/>
<code value="C4873"/>
</coding>
</valueCodeableConcept>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-author">
<valueContactDetail>
<telecom>
<system value="email"/>
<value value="thomas.debertshaeuser@charite.de"/>
</telecom>
</valueContactDetail>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-editor">
<valueContactDetail>
<name value="Taskforce Core Data Set"/>
</valueContactDetail>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-reviewer">
<valueContactDetail>
<name value="Interoperability Working Group"/>
<telecom>
<system value="url"/>
<value
value="https://www.medizininformatik-initiative.de/en/collaboration/interoperability-working-group"/>
</telecom>
</valueContactDetail>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-reviewer">
<valueContactDetail>
<name value="National Steering Committee"/>
<telecom>
<system value="url"/>
<value
value="https://www.medizininformatik-initiative.de/en/collaboration/national-steering-committee"/>
</telecom>
</valueContactDetail>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-endorser">
<valueContactDetail>
<name value="Interoperability Working Group"/>
<telecom>
<system value="url"/>
<value
value="https://www.medizininformatik-initiative.de/en/collaboration/interoperability-working-group"/>
</telecom>
</valueContactDetail>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-endorser">
<valueContactDetail>
<name value="National Steering Committee"/>
<telecom>
<system value="url"/>
<value
value="https://www.medizininformatik-initiative.de/en/collaboration/national-steering-committee"/>
</telecom>
</valueContactDetail>
</extension>
<url
value="https://www.medizininformatik-initiative.de/fhir/ext/modul-seltene/ValueSet/mii-vs-seltene-nbs-acylcarnitine-dbs"/>
<version value="2027.0.0-ballot"/>
<name value="MII_VS_Seltene_NBS_Acylcarnitine_DBS"/>
<title value="MII VS Seltene Erkrankungen NBS Acylcarnitine (Trockenblut)"/>
<status value="active"/>
<experimental value="false"/>
<date value="2026-09-14T21:59:44+00:00"/>
<publisher value="Medizininformatik Initiative"/>
<contact>
<name value="Medizininformatik Initiative"/>
<telecom>
<system value="url"/>
<value value="https://www.medizininformatik-initiative.de/"/>
</telecom>
</contact>
<description
value="Acylcarnitin- und Carnitin-Analyte in Trockenblut (dried blood spot) — die Messgrößen des MS/MS-Acylcarnitinprofils im Neugeborenenscreening (Fettsäureoxidationsstörungen, Organoazidopathien, Carnitinzyklusdefekte). Abgeleitet aus der LOINC-SNOMED-Ontologie und deshalb NICHT vollständig gegenüber LOINC: enthalten ist der nach SNOMED gemappte Teil. Für die lückenlose Menge siehe mii-vs-seltene-nbs-dbs-all."/>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="DE"/>
<display value="Germany"/>
</coding>
</jurisdiction>
<compose>
<include>
<system value="http://loinc.org"/>
<concept>
<code value="50102-3"/>
<display
value="3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53189-7"/>
<display
value="3-Hydroxydodecanoylcarnitine (C12-OH) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53173-1"/>
<display
value="3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="50106-4"/>
<display
value="3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53171-5"/>
<display
value="3-Hydroxyisovalerylcarnitine (C5-OH)/Carnitine.free (C0) [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="53172-3"/>
<display
value="3-Hydroxyisovalerylcarnitine (C5-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="50109-8"/>
<display
value="3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="50113-0"/>
<display
value="3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="50121-3"/>
<display
value="3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="50125-4"/>
<display
value="3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53201-0"/>
<display
value="3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="50132-0"/>
<display
value="3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53196-2"/>
<display
value="3-Hydroxytetradecadienoylcarnitine (C14:2-OH) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="50281-5"/>
<display
value="3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53197-0"/>
<display
value="3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="50157-7"/>
<display value="Acetylcarnitine (C2) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53237-4"/>
<display value="Acrylylcarnitine (C3:1) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="38474-3"/>
<display value="Acylcarnitine [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="43717-8"/>
<display value="Acylcarnitine [Presence] in DBS"/>
</concept>
<concept>
<code value="74628-9"/>
<display value="Adipoylcarnitine (C6-DC) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53613-6"/>
<display value="Benzoylcarnitine (BzCn) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53065-9"/>
<display value="Butyrylcarnitine (C4) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53180-6"/>
<display value="Decadienoylcarnitine (C10:2) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="45197-1"/>
<display value="Decanoylcarnitine (C10) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="45198-9"/>
<display value="Decenoylcarnitine (C10:1) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53214-3"/>
<display
value="Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53213-5"/>
<display
value="Dicarboxydodecenoylcarnitine (C12:1-DC) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53218-4"/>
<display
value="Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53220-0"/>
<display
value="Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53219-2"/>
<display
value="Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53216-8"/>
<display
value="Dicarboxytetradecanoylcarnitine (C14-DC) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53215-0"/>
<display
value="Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="45199-7"/>
<display value="Dodecanoylcarnitine (C12) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="45200-3"/>
<display value="Dodecenoylcarnitine (C12:1) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53462-8"/>
<display value="Eicosanoylcarnitine (C20) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="45207-8"/>
<display value="Glutarylcarnitine (C5-DC) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="88016-1"/>
<display
value="Glutarylcarnitine (C5-DC)/Acetylcarnitine (C2) [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="75225-3"/>
<display
value="Glutarylcarnitine (C5-DC)/Carnitine (C0) [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="75216-2"/>
<display
value="Glutarylcarnitine (C5-DC)/Malonylcarnitine (C3-DC) [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="75267-5"/>
<display
value="Glutarylcarnitine (C5-DC)/Palmitoylcarnitine (C16) [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="88017-9"/>
<display
value="Glutarylcarnitine (C5-DC)/Propionylcarnitine (C3) [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="53204-4"/>
<display value="Heptanoylcarnitine (C7) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="45211-0"/>
<display value="Hexanoylcarnitine (C6) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="45213-6"/>
<display value="Isobutyrylcarnitine (C4) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="42920-9"/>
<display value="Isovalerylcarnitine (C5) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="45217-7"/>
<display value="Linoleoylcarnitine (C18:2) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="54462-7"/>
<display value="Malonylcarnitine (C3-DC) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="75212-1"/>
<display
value="Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="45222-7"/>
<display
value="Methylmalonylcarnitine (C4-DC) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53181-4"/>
<display
value="Methylmalonylcarnitine (C4-DC)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="53207-7"/>
<display value="Nonanoylcarnitine (C9) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53175-6"/>
<display value="Octanoylcarnitine (C8) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53176-4"/>
<display
value="Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="53177-2"/>
<display
value="Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="88014-6"/>
<display
value="Octanoylcarnitine (C8)/Carnitine.free (C0) [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="53174-9"/>
<display value="Octenoylcarnitine (C8:1) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53202-8"/>
<display value="Oleoylcarnitine (C18:1) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53199-6"/>
<display value="Palmitoylcarnitine (C16) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="88015-3"/>
<display
value="Palmitoylcarnitine (C16)/Acetylcarnitine (C2) [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="88024-5"/>
<display
value="Palmitoylcarnitine (C16)/Carnitine.free (C0) [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="54475-9"/>
<display value="Pimeloylcarnitine (C7-DC) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53160-8"/>
<display value="Propionylcarnitine (C3) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53163-2"/>
<display
value="Propionylcarnitine (C3)/Acetylcarnitine (C2) [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="53162-4"/>
<display
value="Propionylcarnitine (C3)/Carnitine.free (C0) [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="53164-0"/>
<display
value="Propionylcarnitine (C3)/Palmitoylcarnitine (C16) [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="53161-6"/>
<display
value="Propionylcarnitine (C3)/Methionine [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="53241-6"/>
<display value="Stearoylcarnitine (C18) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53400-8"/>
<display
value="Stearoylcarnitine (C18)/Propionylcarnitine (C3) [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="53210-1"/>
<display value="Suberylcarnitine (C8-DC) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53190-5"/>
<display
value="Tetradecadienoylcarnitine (C14:2) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53192-1"/>
<display value="Tetradecanoylcarnitine (C14) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53191-3"/>
<display
value="Tetradecenoylcarnitine (C14:1) [Moles/volume] in DBS"/>
</concept>
<concept>
<code value="53193-9"/>
<display
value="Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="53194-7"/>
<display
value="Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="88025-2"/>
<display
value="Tetradecenoylcarnitine (C14:1)/Carnitine.free (C0) [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="53195-4"/>
<display
value="Tetradecenoylcarnitine (C14:1)/Palmitoylcarnitine (C16) [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="70159-9"/>
<display
value="Tetradecenoylcarnitine (C14:1)/Tetradecanoylcarnitine (C14) [Molar ratio] in DBS"/>
</concept>
<concept>
<code value="53170-7"/>
<display value="Tiglylcarnitine (C5:1) [Moles/volume] in DBS"/>
</concept>
</include>
</compose>
</ValueSet>